Kornek et al. reported increased numbers of EVs derived from invariant natural killer T cells and CD14+ monocytes—which are associated with alanine transaminase (ALT)—in plasma samples from NAFLD patients [32]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.